Back to User profile » Dr Marc Miravitlles

Papers published by Dr Marc Miravitlles:


Diaphragmatic Movement at Rest and After Exertion: A Non-Invasive and Easy to Obtain Prognostic Marker in COPD

Mekov E, Yanev N, Kurtelova N, Mihalova T, Tsakova A, Yamakova Y, Miravitlles M, Petkov R

International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:1041-1050

Published Date: 5 May 2022

The Impact of Chronic Bronchial Infection in COPD: A Proposal for Management

Martinez-Garcia MA, Miravitlles M

International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:621-630

Published Date: 23 March 2022

A Pooled Analysis of Mortality in Patients with COPD Receiving Dual Bronchodilation with and without Additional Inhaled Corticosteroid

Miravitlles M, Verhamme K, Calverley PMA, Dreher M, Bayer V, Gardev A, de la Hoz A, Wedzicha J, Price D

International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:545-558

Published Date: 11 March 2022

CONQUEST: A Quality Improvement Program for Defining and Optimizing Standards of Care for Modifiable High-Risk COPD Patients

Alves L, Pullen R, Hurst JR, Miravitlles M, Carter V, Chen R, Couper A, Dransfield M, Evans A, Hardjojo A, Jones D, Jones R, Kerr M, Kostikas K, Marshall J, Martinez F, Melle MV, Murray R, Muro S, Nordon C, Pollack M, Price C, Sharma A, Singh D, Winders T, Price DB

Patient Related Outcome Measures 2022, 13:53-68

Published Date: 23 February 2022

Long-Term Risk of Mortality Associated with Isolation of Pseudomonas aeruginosa in COPD: A Systematic Review and Meta-Analysis

Martinez-García MA, Rigau D, Barrecheguren M, García-Ortega A, Nuñez A, Oscullo Yepez G, Miravitlles M

International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:371-382

Published Date: 16 February 2022

Inhaled Corticosteroid Use Among COPD Patients in Primary Care in Spain

Miravitlles M, Roman-Rodríguez M, Ribera X, Ritz J, Izquierdo JL

International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:245-258

Published Date: 25 January 2022

Opinions and Attitudes of Pulmonologists About Augmentation Therapy in Patients with Alpha-1 Antitrypsin Deficiency. A Survey of the EARCO Group

Greulich T, Albert A, Cassel W, Boeselt T, Peychev E, Klemmer A, Ferreira F, Clarenbach C, Torres-Duran ML, Turner AM, Miravitlles M

International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:53-64

Published Date: 5 January 2022

Economic Impact of Low Adherence to COPD Management Guidelines in Spain

Miravitlles M, Solé A, Aguilar H, Ampudia A, Costa-Samarra J, Mallén-Alberdi M, Nieves D

International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:3131-3143

Published Date: 16 November 2021

Estimated Prevalence and Number of PiMZ Genotypes of Alpha-1 Antitrypsin in Seventy-Four Countries Worldwide

Martinez-González C, Blanco I, Diego I, Bueno P, Miravitlles M

International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:2617-2630

Published Date: 17 September 2021

CONQUEST Quality Standards: For the Collaboration on Quality Improvement Initiative for Achieving Excellence in Standards of COPD Care

Pullen R, Miravitlles M, Sharma A, Singh D, Martinez F, Hurst JR, Alves L, Dransfield M, Chen R, Muro S, Winders T, Blango C, Muellerova H, Trudo F, Dorinsky P, Alacqua M, Morris T, Carter V, Couper A, Jones R, Kostikas K, Murray R, Price DB

International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:2301-2322

Published Date: 12 August 2021

Burden of Disease Among Exacerbating Patients with COPD Treated with Triple Therapy in Spain

Alcázar-Navarrete B, García-Rio F, Sánchez G, Mariscal E, García A, Cuesta M, Uría E, Miravitlles M

International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:2149-2161

Published Date: 21 July 2021

Update on Asthma–COPD Overlap (ACO): A Narrative Review

Mekov E, Nuñez A, Sin DD, Ichinose M, Rhee CK, Maselli DJ, Coté A, Suppli Ulrik C, Maltais F, Anzueto A, Miravitlles M

International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:1783-1799

Published Date: 17 June 2021

Relationship Between Clinical Control, Respiratory Symptoms and Quality of Life for Patients with COPD

Alcazar-Navarrete B, Fuster A, García Sidro P, García Rivero JL, Abascal-Bolado B, Pallarés-Sanmartín A, Márquez E, Valido-Morales A, Boldova Loscertales A, Callejas-Gonzalez FJ, Palop M, Riesco JA, Golpe R, Soler-Cataluña JJ, Miravitlles M

International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:2683-2693

Published Date: 28 October 2020

The Experience of COPD Patients in Lockdown Due to the COVID-19 Pandemic

Pleguezuelos E, Del Carmen A, Moreno E, Ortega P, Vila X, Ovejero L, Serra-Prat M, Palomera E, Garnacho-Castaño MV, Loeb E, Farago G, Miravitlles M

International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:2621-2627

Published Date: 23 October 2020

Trends in Diagnosis of Alpha-1 Antitrypsin Deficiency Between 2015 and 2019 in a Reference Laboratory

Belmonte I, Nuñez A, Barrecheguren M, Esquinas C, Pons M, López-Martínez RM, Ruiz G, Blanco-Grau A, Ferrer R, Genescà J, Miravitlles M, Rodríguez-Frías F

International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:2421-2431

Published Date: 7 October 2020

A Proposed Approach to Chronic Airway Disease (CAD) Using Therapeutic Goals and Treatable Traits: A Look to the Future

Pérez de Llano L, Miravitlles M, Golpe R, Alvarez-Gutiérrez FJ, Cisneros C, Almonacid C, Martinez-Moragon E, Gonzalez-Barcala FJ, Ramos-Barbón D, Plaza V, Lopez-Campos JL, de-Torres JP, Casanova C, Garcia Rivero JL, Rodriguez Hermosa J, Calle Rubio M, Soler-Cataluña JJ, Cosio BG

International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:2091-2100

Published Date: 4 September 2020

Easy to Perform Physical Performance Tests to Identify COPD Patients with Low Physical Activity in Clinical Practice

Matkovic Z, Tudoric N, Cvetko D, Esquinas C, Rahelic D, Zarak M, Miravitlles M

International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:921-929

Published Date: 24 April 2020

Association Between Routine Blood Biomarkers and Clinical Phenotypes and Exacerbations in Chronic Obstructive Pulmonary Disease

Nuñez A, Marras V, Harlander M, Mekov E, Esquinas C, Turel M, Lestan D, Petkov R, Yanev N, Pirina P, Negri S, Miravitlles M, Barrecheguren M

International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:681-690

Published Date: 31 March 2020

Time To Revise COPD Treatment Algorithm

Matsunaga K, Oishi K, Miravitlles M, Anzueto A

International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:2229-2234

Published Date: 27 September 2019

Comparison of clinical baseline characteristics between Asian and Western COPD patients in a prospective, international, multicenter study

Kim KY, Miravitlles M, Sliwinski P, Costello R, Carter V, Tan J, Lapperre TS, Alcazar B, Gouder C, Esquinas C, García-Rivero JL, Kemppinen A, Tee A, Roman-Rodríguez M, Soler-Cataluña JJ, Price D, Rhee CK

International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:1595-1601

Published Date: 25 July 2019

Withdrawal of inhaled corticosteroids in COPD patients: rationale and algorithms

Avdeev S, Aisanov Z, Arkhipov V, Belevskiy A, Leshchenko I, Ovcharenko S, Shmelev E, Miravitlles M

International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:1267-1280

Published Date: 10 June 2019

Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research – a consensus document from six scientific societies [Corrigendum]

Rossi A, Butorac-Petanjek B, Chilosi M, Cosío BG, Flezar M, Koulouris N, Marin J, Miculinic N, Polese G, Samaržija M, Skrgat S, Vassilakopoulos T, Vukić-Dugac A, Zakynthinos S, Miravitlles M

International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:247-248

Published Date: 18 January 2019

Joint statement for the diagnosis, management, and prevention of chronic obstructive pulmonary disease for Gulf Cooperation Council countries and Middle East-North Africa region, 2017 [Corrigendum]

Mahboub BH, Vats MG, Al Zaabi A, Iqbal MN, Safwat T, Al-Hurish F, Miravitlles M, Singh D, Asad K, Zeineldine S, Al Hajjaj MS

International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:115-116

Published Date: 18 January 2019

Russian guidelines for the management of COPD: algorithm of pharmacologic treatment [Corrigendum]

Aisanov Z, Avdeev S, Arkhipov V, Belevskiy A, Chuchalin A, Leshchenko I, Ovcharenko S, Shmelev E, Miravitlles M

International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:243-244

Published Date: 18 January 2019

Bronchiectasis in COPD patients: more than a comorbidity? [Corrigendum]

Martinez-Garcia MA, Miravitlles M

International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:245-246

Published Date: 18 January 2019

Respiratory medication used in COPD patients from seven Latin American countries: the LASSYC study [Corrigendum]

Casas A, Montes de Oca M, Menezes AMB, Wehrmeister FC, Lopez Varela MV, Mendoza L, Ramírez L, Miravitlles M

International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:241-242

Published Date: 18 January 2019

Evaluating the impact of morning symptoms in COPD using the Capacity of Daily Living during the Morning (CDLM) questionnaire

Núñez A, Esquinas C, Barrecheguren M, Calle M, Casamor R, Miravitlles M

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:3837-3844

Published Date: 26 November 2018

Validation of clinical control in COPD as a new tool for optimizing treatment

Soler-Cataluña JJ, Marzo M, Catalán P, Miralles C, Alcazar B, Miravitlles M

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:3719-3731

Published Date: 14 November 2018

How whole-body vibration can help our COPD patients. Physiological changes at different vibration frequencies

Pleguezuelos E, Casarramona P, Guirao L, Samitier B, Ortega P, Vila X, Del Carmen A, Ovejero L, Moreno E, Serra N, Gomís M, Garnacho-Castaño MV, Miravitlles M

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:3373-3380

Published Date: 18 October 2018

Prevalence of smoking in a psychiatric hospital and its relationship with respiratory symptoms and the prevalence of COPD

Lores L, Monje A, Bergada M, Arellano E, Rodríguez-Larrea J, Miravitlles M

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:2797-2804

Published Date: 7 September 2018

Respiratory medication used in COPD patients from seven Latin American countries: the LASSYC study

Casas A, Montes de Oca M, Menezes AMB, Wehrmeister FC, Lopez Varela MV, Mendoza L, Ramírez L, Miravitlles M

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:1545-1556

Published Date: 11 May 2018

Exacerbation heterogeneity in COPD: subgroup analyses from the FLAME study

Vogelmeier CF, Chapman KR, Miravitlles M, Roche N, Vestbo J, Thach C, Banerji D, Fogel R, Patalano F, Olsson P, Kostikas K, Wedzicha JA

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:1125-1134

Published Date: 10 April 2018

Long-term evolution of lung function in individuals with alpha-1 antitrypsin deficiency from the Spanish registry (REDAAT)

Esquinas C, Serreri S, Barrecheguren M, Rodríguez E, Nuñez A, Casas-Maldonado F, Blanco I, Pirina P, Lara B, Miravitlles M

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:1001-1007

Published Date: 23 March 2018

Depressive status explains a significant amount of the variance in COPD assessment test (CAT) scores

Miravitlles M, Molina J, Quintano JA, Campuzano A, Pérez J, Roncero C

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:823-831

Published Date: 6 March 2018

Mixed Th2 and non-Th2 inflammatory pattern in the asthma–COPD overlap: a network approach

Pérez de Llano L, Cosío BG, Iglesias A, de las Cuevas N, Soler-Cataluña JJ, Izquierdo JL, López-Campos JL, Calero C, Plaza V, Miravitlles M, Torrego A, Martinez‐Moragon E, Soriano JB, Lopez Viña A, Bobolea I

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:591-601

Published Date: 12 February 2018

Russian guidelines for the management of COPD: algorithm of pharmacologic treatment

Aisanov Z, Avdeev S, Arkhipov V, Belevskiy A, Chuchalin A, Leshchenko I, Ovcharenko S, Shmelev E, Miravitlles M

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:183-187

Published Date: 8 January 2018

Geographical distribution of COPD prevalence in Europe, estimated by an inverse distance weighting interpolation technique

Blanco I, Diego I, Bueno P, Fernández E, Casas-Maldonado F, Esquinas C, Soriano JB, Miravitlles M

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:57-67

Published Date: 21 December 2017

Gene and miRNA expression profiles in PBMCs from patients with severe and mild emphysema and PiZZ alpha1-antitrypsin deficiency

Esquinas C, Janciauskiene S, Gonzalo R, Mas de Xaxars G, Olejnicka B, Belmonte I, Barrecheguren M, Rodríguez E, Nuñez A, Rodríguez-Frías F, Miravitlles M

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:3381-3390

Published Date: 29 November 2017

Joint statement for the diagnosis, management, and prevention of chronic obstructive pulmonary disease for Gulf Cooperation Council countries and Middle East–North Africa region, 2017

Mahboub BH, Vats MG, Al Zaabi A, Iqbal MN, Safwat T, Al-Hurish F, Miravitlles M, Singh D, Asad K, Zeineldine S, Al-Hajjaj MS

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2869-2890

Published Date: 9 October 2017

Impact and prevention of severe exacerbations of COPD: a review of the evidence

Halpin DMG, Miravitlles M, Metzdorf N, Celli B

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2891-2908

Published Date: 5 October 2017

Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research – a consensus document from six scientific societies

Rossi A, Butorac-Petanjek B, Chilosi M, Cosío BG, Flezar M, Koulouris N, Marin J, Miculinic N, Polese G, Samaržija M, Skrgat S, Vassilakopoulos T, Vukić-Dugac A, Zakynthinos S, Miravitlles M

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2593-2610

Published Date: 29 August 2017

When is dual bronchodilation indicated in COPD?

Thomas M, Halpin DMG, Miravitlles M

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2291-2305

Published Date: 3 August 2017

Palliative care and prognosis in COPD: a systematic review with a validation cohort

Almagro P, Yun S, Sangil A, Rodríguez-Carballeira M, Marine M, Landete P, Soler-Cataluña JJ, Soriano JB, Miravitlles M

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1721-1729

Published Date: 9 June 2017

Alpha-1 antitrypsin Pi*SZ genotype: estimated prevalence and number of SZ subjects worldwide

Blanco I, Bueno P, Diego I, Pérez-Holanda S, Lara B, Casas-Maldonado F, Esquinas C, Miravitlles M

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1683-1694

Published Date: 8 June 2017

Bronchiectasis in COPD patients: more than a comorbidity?

Martinez-Garcia MA, Miravitlles M

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1401-1411

Published Date: 11 May 2017

Does co-payment for inhaler devices affect therapy adherence and disease outcomes? A historical, matched cohort study

Voorham J, Vrijens B, van Boven JFM, Ryan D, Miravitlles M, Law LM, Price DB

Pragmatic and Observational Research 2017, 8:31-41

Published Date: 18 April 2017

Self-reported daily walking time in COPD: relationship with relevant clinical and functional characteristics

Ramon MA, Esquinas C, Barrecheguren M, Pleguezuelos E, Molina J, Quintano JA, Roman-Rodríguez M, Naberan K, Llor C, Roncero C, Miravitlles M

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1173-1181

Published Date: 13 April 2017

Alpha-1 antitrypsin Pi*Z gene frequency and Pi*ZZ genotype numbers worldwide: an update

Blanco I, Bueno P, Diego I, Pérez-Holanda S, Casas-Maldonado F, Esquinas C, Miravitlles M

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:561-569

Published Date: 13 February 2017

Application of a diagnostic algorithm for the rare deficient variant Mmalton of alpha-1-antitrypsin deficiency: a new approach

Belmonte I, Barrecheguren M, López-Martínez RM, Esquinas C, Rodríguez E, Miravitlles M, Rodríguez-Frias F

International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:2535-2541

Published Date: 11 October 2016

Diagnosis of alpha-1 antitrypsin deficiency: a population-based study

Barrecheguren M, Monteagudo M, Simonet P, Llor C, Rodriguez E, Ferrer J, Esquinas C, Miravitlles M

International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:999-1004

Published Date: 10 May 2016

POPE study: rationale and methodology of a study to phenotype patients with COPD in Central and Eastern Europe

Zbozinkova Z, Barczyk A, Tkacova R, Valipour A, Tudoric N, Zykov K, Somfay A, Miravitlles M, Koblizek V

International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:611-622

Published Date: 22 March 2016

Cognitive status among patients with chronic obstructive pulmonary disease

Roncero C, Campuzano AI, Quintano JA, Molina J, Pérez J, Miravitlles M

International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:543-551

Published Date: 16 March 2016

Treatment of patients with COPD and recurrent exacerbations: the role of infection and inflammation

Santos S, Marin A, Serra-Batlles J, de la Rosa D, Solanes I, Pomares X, López-Sánchez M, Muñoz-Esquerre M, Miravitlles M

International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:515-525

Published Date: 11 March 2016

A cross-sectional study to assess inhalation device handling and patient satisfaction in COPD

Miravitlles M, Montero-Caballero J, Richard F, Santos S, Garcia-Rivero JL, Ortega F, Ribera X

International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:407-415

Published Date: 26 February 2016

Cost-effectiveness of combination therapy umeclidinium/vilanterol versus tiotropium in symptomatic COPD Spanish patients

Miravitlles M, Gáldiz JB, Huerta A, Villacampa A, Carcedo D, Garcia-Rio F

International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:123-132

Published Date: 18 January 2016

The chronic obstructive pulmonary disease assessment test improves the predictive value of previous exacerbations for poor outcomes in COPD

Miravitlles M, García-Sidro P, Fernández-Nistal A, Buendía MJ, Espinosa de los Monteros MJ, Esquinas C, Molina J

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:2571-2579

Published Date: 30 November 2015

The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK

Brusselle G, Price D, Gruffydd-Jones K, Miravitlles M, Keininger DL, Stewart R, Baldwin M, Jones RC

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:2207-2217

Published Date: 15 October 2015

Is a previous diagnosis of asthma a reliable criterion for asthma–COPD overlap syndrome in a patient with COPD?

Barrecheguren M, Román-Rodríguez M, Miravitlles M

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:1745-1752

Published Date: 1 September 2015

What pulmonologists think about the asthma–COPD overlap syndrome

Miravitlles M, Alcázar B, Alvarez FJ, Bazús T, Calle M, Casanova C, Cisneros C, de-Torres JP, Entrenas LM, Esteban C, García-Sidro P, Cosio BG, Huerta A, Iriberri M, Izquierdo JL, López-Viña A, López-Campos JL, Martínez-Moragón E, Pérez de Llano L, Perpiñá M, Ros JA, Serrano J, Soler-Cataluña JJ, Torrego A, Urrutia I, Plaza V

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:1321-1330

Published Date: 15 July 2015

Prognostic factors for clinical failure of exacerbations in elderly outpatients with moderate-to-severe COPD

Wilson R, Anzueto A, Miravitlles M, Arvis P, Haverstock D, Trajanovic M, Sethi S

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:985-993

Published Date: 2 June 2015

Clinical variables impacting on the estimation of utilities in chronic obstructive pulmonary disease

Miravitlles M, Huerta A, Valle M, García-Sidro P, Forné C, Crespo C, López-Campos JL

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:367-377

Published Date: 16 February 2015

Caregivers’ burden in patients with COPD

Miravitlles M, Peña-Longobardo LM, Oliva-Moreno J, Hidalgo-Vega Á

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:347-356

Published Date: 12 February 2015

The concept of control of COPD in clinical practice

Soler-Cataluña JJ, Alcázar-Navarrete B, Miravitlles M

International Journal of Chronic Obstructive Pulmonary Disease 2014, 9:1397-1405

Published Date: 12 December 2014

Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns

Price D, West D, Brusselle G, Gruffydd-Jones K, Jones R, Miravitlles M, Rossi A, Hutton C, Ashton VL, Stewart R, Bichel K

International Journal of Chronic Obstructive Pulmonary Disease 2014, 9:889-905

Published Date: 27 August 2014

COPD management: role of symptom assessment in routine clinical practice

van der Molen T, Miravitlles M, Kocks JWH

International Journal of Chronic Obstructive Pulmonary Disease 2013, 8:461-471

Published Date: 14 October 2013

Beyond FEV1 in COPD: a review of patient-reported outcomes and their measurement

Jones P, Miravitlles M, van der Molen T, Kulich K

International Journal of Chronic Obstructive Pulmonary Disease 2012, 7:697-709

Published Date: 16 October 2012

A novel study design for antibiotic trials in acute exacerbations of COPD: MAESTRAL methodology

Wilson R, Anzueto A, Miravitlles M, Arvis P, Faragó G, Haverstock D, Trajanovic M, Sethi S

International Journal of Chronic Obstructive Pulmonary Disease 2011, 6:373-383

Published Date: 29 June 2011

Geographic differences in clinical characteristics and management of COPD: the EPOCA study

Marc Miravitlles, Cristina Murio, Gema Tirado-Conde, Gur Levy, Hana Muellerova, et al

International Journal of Chronic Obstructive Pulmonary Disease 2008, 3:803-814

Published Date: 5 December 2008

Efficacy of amoxycillin versus amoxycillin/clavulanate in acute exacerbations of chronic pulmonary obstructive disease in primary care

Carl Llor, Silvia Hernández, Anna Ribas, Carmen Álvarez, Josep Maria Cots, et al

International Journal of Chronic Obstructive Pulmonary Disease 2009, 4:45-53

Published Date: 15 October 2008